Jessica Perl

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jessica Perl:

Company Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. SVP, General Counsel, Corp Sec Common Stock 68,387 $396,645 $5.80 06 Mar 2025 Direct
Emergent BioSolutions Inc. SVP, General Counsel, Corp Sec Employee Stock Options (Right to Buy) 95,945 06 Mar 2025 Direct

Insider Reports Filed by Jessica Perl

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 06 Mar 2025 2 $0 4 SVP, General Counsel, Corp Sec 10 Mar 2025, 16:18
EBS Emergent BioSolutions Inc. 09 Feb 2025 1 -$9,180 4 SVP, General Counsel, Corp Sec 11 Feb 2025, 16:01
EBS Emergent BioSolutions Inc. 29 Oct 2024 0 $0 3 SVP, General Counsel, Corp Sec 12 Nov 2024, 16:26